KURA Francis Burrows sells $232K worth of shares
Dec 20, 2025, 5:36 AM
0.00%
What does KURA do
Kura Oncology, headquartered in San Diego, focuses on developing precision medicines for cancer treatment, including small molecule candidates Ziftomenib, Tipifarnib, and KO-2806. The company went public in November 2015 and employs 142 staff.
Francis Burrows sold 23,726 shares of KURA on 18 December at $9.78 per share, worth a total of $232K. They now own 33,735 KURA shares, or a 41% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.